IntusCare
PrivateLast Round
Growth Equity
Mar 16, 2026
Total Funding Raised
$30.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
IntusCare operates in Healthcare & Life Sciences and is based in Providence, Rhode Island. Its latest recorded funding round was a Strategic round in January 2025.
IntusCare is a healthcare technology company that develops a predictive analytics platform and electronic medical record (EMR) ecosystem designed to improve geriatric care for Programs of All-Inclusive Care for the Elderly (PACE).
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Healthcare Analytics, Compliance & Risk, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IntusCare Comparables
Compare IntusCare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Collabrios Health | 87% | |
| August Health | 78% | |
| Saisystems International | 75% |
For institutional investors. Book with your work email.
IntusCare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Mar 16, 2026 | ||||
| Early Funding | Apr 18, 2025 | ||||
| Strategic | Jan 16, 2025 | ||||
| Series A | Nov 2, 2022 | ||||
| Seed | Apr 20, 2022 | ||||
Seed | Apr 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IntusCare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Strategic, Series A |
| Jumpstart Health Investors | Seed |
| Jumpstart Nova | Strategic, Seed |
| Waterman Ventures | Seed |
| Collab Capital | Seed |
| General Catalyst | Growth Equity, Seed |
| Preface Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, from 5.5K to 7.5K.
- Mar 16, 2026
$539K raised in Seed Round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 12, 2026
IntusCare attends the 2026 National PACE Association Annual Conference in Colorado in Oct '26, where its leaders and clinicians present alongside AnewHealth and the organizations unveil a new integration between EireneRx and CareHub.
- launchesOct 6, 2026
IntusCare announces an expanded IRIS platform that connects clinical documentation, CMS submission tracking, reconciliation, and financial analytics across the risk adjustment lifecycle for PACE organizations in New York on Oct 6th '26.
For institutional investors. Book with your work email.
IntusCare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IntusCare's valuation, stock price, and market status.
Is IntusCare a public or private company?
IntusCare is a private company.
What is the current stock price of IntusCare?
IntusCare is a private company, so its shares have no public market price. Caplight tracks IntusCare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IntusCare worth (valuation)?
Valuation information for IntusCare is not publicly available.
Can I buy IntusCare stock?
IntusCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IntusCare's last funding round?
IntusCare's most recent funding round was Growth Equity on March 16, 2026.
Who are the main investors in IntusCare?
Key investors in IntusCare include Deerfield Management, 3CC | Third Culture Capital, Blue Star Innovation Partners, Equal Opportunity (EO) Ventures.
Will IntusCare IPO soon?
No public IPO plans have been announced for IntusCare.
How can I track IntusCare secondary market activity?
Caplight tracks bids, offers, and trades in IntusCare's shares on secondary markets.